These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35132320)

  • 1. Long Noncoding RNA RMRP Contributes to Paclitaxel Sensitivity of Ovarian Cancer by Regulating miR-580-3p/MICU1 Signaling.
    Li L; Zeng S; Guo L; Huang P; Xi J; Feng J; Li Q; Li Y; Xiao X; Yan R; Zhang J
    J Oncol; 2022; 2022():8301941. PubMed ID: 35132320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression.
    Huang C; Qin L; Chen S; Huang Q
    Anticancer Drugs; 2023 Mar; 34(3):395-404. PubMed ID: 36729852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA TUG1 Promotes Autophagy-Associated Paclitaxel Resistance by Sponging miR-29b-3p in Ovarian Cancer Cells.
    Gu L; Li Q; Liu H; Lu X; Zhu M
    Onco Targets Ther; 2020; 13():2007-2019. PubMed ID: 32189969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
    Lin H; Shen L; Lin Q; Dong C; Maswela B; Illahi GS; Wu X
    Biomed Pharmacother; 2020 Mar; 123():109711. PubMed ID: 31884343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194.
    An J; Lv W; Zhang Y
    Onco Targets Ther; 2017; 10():5377-5390. PubMed ID: 29180871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis.
    Ying H; Zhao R; Yu Q; Zhang K; Deng Q
    Drug Dev Res; 2022 Apr; 83(2):512-524. PubMed ID: 34541682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
    Liu YY; Zhang LY; Du WZ
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252.
    Zhang S; Cheng J; Quan C; Wen H; Feng Z; Hu Q; Zhu J; Huang Y; Wu X
    Mol Ther Nucleic Acids; 2020 Mar; 19():718-730. PubMed ID: 31945729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis.
    Huang B; Wei M; Hong L
    Open Life Sci; 2021; 16(1):667-681. PubMed ID: 34250246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465.
    Zhao H; Wang A; Zhang Z
    J Biochem; 2020 Aug; 168(2):171-181. PubMed ID: 32211849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
    Li L; Shou H; Wang Q; Liu S
    Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
    Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-526b-3p Attenuates Breast Cancer Stem Cell Properties and Chemoresistance by Targeting HIF-2α/Notch Signaling.
    Liu JH; Li WT; Yang Y; Qi YB; Cheng Y; Wu JH
    Front Oncol; 2021; 11():696269. PubMed ID: 35004266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway.
    Yang H; Wang J; Zhang Z; Peng R; Lv D; Liu H; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():690784. PubMed ID: 34512545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer.
    Zhu J; Luo JE; Chen Y; Wu Q
    J Ovarian Res; 2021 Oct; 14(1):136. PubMed ID: 34649611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
    Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
    Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA RMRP promotes proliferation and invasion via targeting miR-1-3p in non-small-cell lung cancer.
    Wang Y; Luo X; Liu Y; Han G; Sun D
    J Cell Biochem; 2019 Sep; 120(9):15170-15181. PubMed ID: 31050363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-212-3p inhibits paclitaxel resistance through regulating epithelial-mesenchymal transition, migration and invasion by targeting ZEB2 in human hepatocellular carcinoma.
    Yang J; Cui R; Liu Y
    Oncol Lett; 2020 Oct; 20(4):23. PubMed ID: 32774496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.